Advanced Search

 

Study ID Status Title Patient Level Data
201224 Completed Meta-Analysis Plan for GSK1550188, 201224, Concomitant Medications Analysis
201233 Completed Meta-analysis of DB2116132 and DB2116133. An integrated review to evaluate dose reponse of GSK573719 administered once daily in subjects with COPD
201235 Completed PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
201280 Active not recruiting Evidence synthesis to assess comparative efficacy of UMEC versus other treatments for COPD adult patients
201315 Completed A Randomized, Parallel-group, Open-label Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Glycopyrronium 44 mcg in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
201316 Completed A Randomized, Blinded, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Tiotropium 18 mcg in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
201351 Completed A Randomized, Placebo Controlled, Repeat Dose, Double Blind (sponsor unblind) Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered with Metformin to Type 2 Diabetes Patients Study Listed on ClinicalStudyDataRequest.com
201357 Active not recruiting Health care resource use and costs associated with use of mepolizumab versus placebo in a clinical trial setting
201363 Completed Treatment Pathways in an Inception Lupus Cohort in Atlantic Canada
201402 Completed A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions Study Listed on ClinicalStudyDataRequest.com
201426 Completed PRJ2250: Survey of patient and prescriber understanding of risks associated with TROBALT
201450 Not yet recruiting ENCRUSE ELLIPTA Drug Use Investigation
201474 Completed A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
201514 Active not recruiting Impact of initiating maintenance treatment (MT) promptly post-chronic obstructive pulmonary disease (COPD) exacerbation in a managed care setting
201527 Completed Comparative Randomized, Single dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole from Idiazole 20mg DR tabs (GSK, Egypt)and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a Single Oral Dose Administration of each to Healthy Adults under Fasting Conditions
201528 Completed Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Rabeprazole from Raperazole 20mg DR tabs (GSK, Egypt) and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a single oral dose administration of each to healthy adults under fed conditions
201529 Completed Comparative Randomized, Single Dose, Two-way Crossover, Open-label Study to Determine the Bioequivalence of Cefadroxil from Duricef 1 gm Film Coated Tablets (Smithkline Beecham Egypt, LLC Affiliated Co. to GalaxoSmithKline ) and Biodroxil 1 gm Film Coated tablets (Kahira Pharm &Chem .Ind. Co. for Novartis Pharma ) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
201539 Active not recruiting A retrospective data collection of the parameters required as per Belgian reimbursement criteria in SLE patients having received belimumab
201657 Completed Meta-analysis of clinical efficacy studies of licensed Rheumatoid Arthritis (RA) treatments
201713 Completed An Open-label, Randomized, Single Dose, Three-way Crossover, Six Sequence Pilot Study to Determine the Relative Bioavailability of Candesartan Cilexetil 16mg From Two Candidate Tablet Formulations of GW615775 Relative to One 16mg Tablet of Reference Candesartan Cilexetil in Healthy Adult Human Subjects Under Fasting Conditions
201724 Active not recruiting HO-14-15325 - Cost of Illness Associated with Early Combination Treatment of BPH in the US
201804 Active not recruiting PRJ2335: An Observational Study of the Risk of Acute Pancreatitis in Subjects Exposed to Albiglutide, Other GLP-1 Agonists and DPP-4 Inhibitors Compared to Other Antidiabetic Agents
201805 Active not recruiting PRJ2331: An Observational Study of the Risk of Malignant Neoplasms and Malignant Neoplasms of Special Interest (Thyroid and Pancreatic Cancer) in Subjects Treated with Albiglutide Compared to Those Treated with Other Antidiabetic Agents
201908 Active not recruiting HO-14-15413 - Evidence Synthesis and Mixed Treatment Comparison of Efficacy of Treatments for the Maintenance of Asthma (annual updates)
201909 Completed An open-label study investigating critical and overall errors following 14 days of treatment with SERETIDE Metered Dose Inhaler (EVOHALER) in adult subjects with controlled asthma currently using the SERETIDE DISKUS Inhaler Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.